Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Min-Ho ParkJae Hong SeoJung Ho ParkMin-Ki SeongKeon Uk ParkMin Kyoon KimMyung Chul ChangSu Jin KohMoon Hee LeeSeung Taek LimYoung-Bum YooSo Yeon OhSung Hyun KimKeum Young AhnTae Hong ParkHana JuEric Hyungseok BaekSinhye KimNahyun KimEunkyung LeeTae Hyun KimPublished in: Expert opinion on biological therapy (2024)
In a real-world setting, CT-P6 demonstrated safety and efficacy findings consistent with previous CT-P6 studies.